Stock

Nasdaq:

DEPO

Price:

3.09 -0.18

Volume:

389,637

20 minute delay

In The News

June 11, 2009 Depomed to Present at Jefferies 3rd Annual Healthcare Conference

June 3, 2009 Depomed to Present at Needham & Company's 8th Annual Life Sciences Conference

June 2, 2009 Depomed Completes Enrollment of Phase 3 Clinical Program of DM-1796 in Post-Herpetic Neuralgia

June 1, 2009 Depomed Names Shay Weisbrich Vice President of Marketing

May 19, 2009 Depomed to Host Investor Day in New York City - RSVP Requested